de Wit, Douwe F. http://orcid.org/0000-0002-2124-4915
Fuhri Snethlage, Coco M. http://orcid.org/0009-0009-4166-5045
Rampanelli, Elena http://orcid.org/0000-0002-7742-0092
Maasen, Kim http://orcid.org/0000-0003-0494-0983
Walpot, Noortje
van Raalte, Daniƫl H. http://orcid.org/0000-0003-2894-6124
Nieuwdorp, Max http://orcid.org/0000-0002-1926-7659
Soeters, Maarten R. http://orcid.org/0000-0001-5008-6752
Hanssen, Nordin M. J. http://orcid.org/0000-0001-9541-7244
Funding for this research was provided by:
Novo Nordisk Foundation CAMIT grant 2022 (23130)
Senior Clinical Dekker grant (2021T055)
NWO VIDI grant 2023 (09150172210019)
NWO VICI grant (09150182010020)
Article History
Received: 29 January 2024
Accepted: 26 April 2024
First Online: 5 July 2024
Acknowledgements
: A peer reviewed version of this article was presented at the Annual Dutch Diabetes Research Meeting (ADDRM) 2023 on 2 November 2023.
: The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request.
: This research was supported by a DON DNF grant 2020 (2020.10.002) to CMFS and NMJH. DFdW was supported by a Novo Nordisk Foundation CAMIT grant 2022 (23130) to MN. NMJH is supported by a Senior Clinical Dekker grant by the Dutch Heart Foundation (grant 2021T055) and an NWO VIDI grant 2023 (09150172210019). MN is supported by a personal NWO VICI grant 2020 (09150182010020). DHvR is supported by grants from the Dutch Diabetes Foundation and Dutch Kidney Foundation.
: MN is a scientific advisory board member of Caelus Pharmaceuticals and Advanced Microbiome Interventions, the Netherlands. DHvR has acted as a consultant for and received honoraria from Boehringer Ingelheim-Lilly Diabetes Alliance, Merck, Sanofi and AstraZeneca and has received research operating funds from Boehringer Ingelheim-Lilly Diabetes Alliance, AstraZeneca and Merck. All honoraria are paid to his employer. NMJH has received honoraria from Boehringer Ingelheim and Novo Nordisk. MRS is a scientific advisory board member of Clear.bio, the Netherlands. None of these interests are relevant to this article. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: ER, CMFS, MN, MRS and NMJH contributed to the design of the study. NMJH supervised the data collection. CMFS and ER contributed to the data collection. DFdW, CMFS and NW contributed to the data cleaning. DHvR, KM and MRS contributed to the analysis and interpretation of the data. DFdW wrote the initial draft of the manuscript. CMFS, ER, KM, DHvR, NW and MN critically reviewed the manuscript for important intellectual content. NMJH and MRS edited the manuscript. All authors approved the final version of the manuscript. NMJH is the guarantor of this work.